Innerwell combines personalized guidance from licensed therapists with cutting-edge psychedelic medicine. Now serving patients in Arizona, California, Colorado, Connecticut, Florida, New Jersey, New York, Ohio, Oregon, Utah, Texas, Virginia, Minnesota and Washington State. || Innerwell Reflections

Innerwell Reflections

Reflections

Find a Clinician by State

Find a Psychiatrist

Find a Therapist

Find Ketamine Treatment

Find EMDR Therapy

EMDR

Ketamine Treatment

Psychedelic Integration

psychiatry

therapy

mental-health

arizona-mental-health

california-mental-health

colorado-mental-health

connecticut-mental-health

Delaware

florida-mental-health

georgia-mental-health

idaho-mental-health

illinois-mental-health

iowa-mental-health

Kentucky

maine-mental-health

massachusetts-mental-health

michigan-mental-health

minnesota-mental-health

montana-mental-health

Nebraska

nevada-mental-health

new-hampshire-mental-health

new-jersey-mental-health

new-york-mental-health

north-carolina-mental-health

ohio-mental-health

oregon-mental-health

pennsylvania-mental-health

tennessee-mental-health

texas-mental-health

utah-mental-health

vermont-mental-health

virginia-mental-health

washington-mental-health

wisconsin-mental-health

 Personalized Mental Health Support from Wyoming Specialists

About

Refer a Patient to Innerwell

Work With Us

Reviews

Why Innerwell

Contact

Affiliate Program

Ketamine for Depression

Ketamine for Anxiety

Ketamine for PTSD

Ketamine for Postpartum Depression

Welcome! What service are you primarily interested in?

Innerwell Privacy Policy

Terms & Conditions

Innerwell Telehealth and Informed Consent

Notice of Privacy Practices

Page Not found. It's okay, we all get a little lost from time to time. 

Find Therapy & Counseling Services Near Me

KBS, Inc. and its affiliates (“Innerwell”) provide a platform that connects medical professionals with individuals. Innerwell does not control or direct the activity of the medical professionals providing care through the platform. Innerwell does not provide medical advice and nothing on the platform should be considered medical advice.

If you've tried SSRIs and they didn't work, whether because of side effects like sexual dysfunction or weight gain, or simply because your depression didn't budge, you're not alone. About one-third of people with major depression don't respond to first-line treatments.

The good news: SSRIs aren't your only option. There are FDA-approved medications that work through different brain pathways, therapy approaches with efficacy comparable to medication, brain stimulation treatments, and rapid-acting options like ketamine therapy you can do at home that can produce relief within hours rather than weeks.

Below, we'll cover the evidence-based alternatives and help you figure out which direction might make sense for your situation.

SSRIs (selective serotonin reuptake inhibitors) are the most commonly prescribed antidepressants. They work by blocking the reabsorption of serotonin in the brain, leaving more of this "feel-good" neurotransmitter available to improve mood and reduce anxiety.

Common SSRIs include sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), paroxetine (Paxil), and citalopram (Celexa). They're typically the first medication doctors try because they're effective for many people and generally well-tolerated compared to older antidepressants.

Despite being effective for many, SSRIs fail a significant portion of people with depression. Understanding why can help you identify which alternative might work better.

The serotonin hypothesis has limits. SSRIs assume that low serotonin causes depression, but depression is more complex than a single neurotransmitter imbalance. For some people, other brain systems like dopamine, norepinephrine, or glutamate play a bigger role.

Side effects force discontinuation. Sexual dysfunction affects up to 70% of SSRI users. Weight gain, emotional blunting, and sleep disruption are also common. When side effects outweigh benefits, alternatives become necessary.

Treatment-resistant depression is common. When depression doesn't respond adequately to two or more antidepressant trials, it's not a personal failure. It's a sign that a different mechanism of action may be needed. Learn more about treatment-resistant depression.

Onset takes too long. SSRIs typically require 4-6 weeks to show full effects. For people with severe symptoms, that timeline can feel unbearable, especially when there's no guarantee the medication will work.

If any of this sounds familiar, the alternatives below offer different approaches worth considering.

SNRIs block reuptake of both serotonin and norepinephrine. Pooled analyses show venlafaxine demonstrates higher remission rates than some SSRIs (45% vs 35%), though this advantage must be weighed against more challenging discontinuation.

Venlafaxine (Effexor) may work faster than SSRIs for some people, but it's particularly difficult to stop. Withdrawal symptoms can be more pronounced than with other antidepressants.

Duloxetine (Cymbalta) is a strong choice if you have chronic pain alongside depression. Clinical guidelines specifically recommend it for people with pain comorbidity.

Desvenlafaxine (Pristiq) offers more predictable dosing since it doesn't require metabolic conversion, though it shares similar discontinuation challenges.

Bupropion (Wellbutrin) stands apart from other antidepressants because it targets dopamine and norepinephrine rather than serotonin. This different mechanism explains its unique advantages: lower sexual dysfunction rates compared to SSRIs and generally weight-neutral effects. Research indicates it's particularly effective for atypical depression with hypersomnia, fatigue, or increased appetite.

The trade-off: Bupropion carries the highest seizure risk among antidepressants. It's absolutely contraindicated if you have a seizure disorder, bulimia, anorexia, or if you're discontinuing alcohol or sedatives.

Mirtazapine (Remeron) works well if insomnia is a major problem. About 54% of people experience therapeutic sedation, which can be a feature rather than a bug. It also shows faster onset than many SSRIs and lower sexual dysfunction rates. The main downsides are sedation and weight gain.

Evidence-based psychotherapy demonstrates comparable efficacy to SSRIs for acute depression treatment. Cognitive behavioral therapy (CBT) and interpersonal therapy (IPT) both have strong research support, and combining medication with therapy produces better outcomes than either alone.

Transcranial Magnetic Stimulation (TMS) uses magnetic pulses to stimulate brain regions involved in mood regulation. It's FDA-approved for treatment-resistant depression with remission rates ranging from 20% to 63% depending on the protocol. Unlike ECT, TMS requires no anesthesia and causes no memory problems. Standard protocols involve 30 daily sessions over 4-6 weeks.

Electroconvulsive Therapy (ECT) remains the most effective acute treatment for severe depression, with 80% response rates. It's typically reserved for severe, treatment-resistant cases when rapid response is medically necessary.

Rapid-Acting Alternatives: Ketamine Therapy

If you've tried multiple antidepressants without success, ketamine therapy represents a fundamentally different approach. Rather than targeting serotonin over weeks, ketamine works through the glutamate system and can produce noticeable effects within hours to days.

According to meta-analysis, IV ketamine shows response rates three times higher than placebo. FDA-approved esketamine (Spravato) provides a 20% improvement advantage over placebo in response rates.

This speed matters. When you've been waiting weeks for each medication trial to fail, a treatment that can show results within days changes the calculus entirely.

The consideration: Ketamine isn't a permanent fix. Effects from single sessions typically last one to three weeks, which is why most protocols involve multiple treatments. But for many people, that rapid relief provides a window to build momentum with therapy and other changes.

Consider SNRIs or atypical antidepressants if:

You've had inadequate response to SSRIs but aren't ready to move beyond oral medications. If sexual dysfunction or weight gain were the main problems, bupropion may be worth discussing. If insomnia is significant, mirtazapine's sedating effects might actually help.

You've tried multiple medication approaches without success and can access specialized treatment centers. TMS is less invasive with minimal side effects; ECT is more intensive but more effective for severe depression.

You haven't responded adequately to at least two antidepressant trials, need faster relief due to severe symptoms, and have no contraindicated conditions (uncontrolled high blood pressure, history of psychosis, severe heart disease, or pregnancy).

The strongest case for ketamine is when you're stuck: you've tried the standard approaches, they haven't worked, and you need something that works through a different mechanism entirely.

How Innerwell's At-Home Ketamine Therapy Works

If you're considering ketamine therapy, the practical questions matter: How do you actually access it? What does treatment look like? What does it cost?

Innerwell delivers sublingual ketamine tablets to your door, paired with licensed therapist support throughout treatment. This isn't ketamine dropped off with minimal supervision. It's a comprehensive program designed to maximize the therapeutic window that ketamine opens.

Ketamine promotes neuroplasticity, essentially making your brain more capable of forming new connections. But that window is most valuable when paired with therapeutic work. The medication opens a door; therapy helps you walk through it.

Evaluation: A virtual psychiatric assessment determines whether ketamine is appropriate for you and builds a personalized protocol.

Delivery: Once approved, you receive sublingual ketamine tablets shipped securely to your home with blood pressure monitoring equipment, dosing instructions, and direct clinician access.

Preparation and integration: Before treatment, you work with a licensed therapist to set intentions and understand what to expect. After ketamine sessions, integration therapy helps you process insights and apply them to daily life. All therapists hold Master's or Doctoral degrees with specialized training in ketamine-assisted psychotherapy.

Ongoing monitoring: Your care team tracks progress and adjusts treatment as needed.

Innerwell's insurance partnerships bring costs significantly below typical ketamine therapy pricing:

Foundation Plan (8 sessions): $599 with insurance ($75/treatment) or $998 self-pay ($125/treatment)

Extended Plan (24 sessions): $1,299 with insurance (as low as $54/treatment) or $1,999 self-pay ($83/treatment)

Compare this to IV ketamine at $400-800 per session or competitors charging $200+ per session.

People using Innerwell achieve measurable improvements: 69% reduction in depression symptoms and 60% reduction in anxiety symptoms after 10 weeks of treatment. 87% see improvement within 4 weeks.

Ready to explore if ketamine therapy might be right for you? Take our free assessment to see if at-home ketamine-assisted therapy could help.

How do I know if I'm a candidate for SSRI alternatives?

You may be a candidate if you've tried at least one SSRI for an adequate duration (typically 6-8 weeks at therapeutic doses) without sufficient improvement, or if you experienced intolerable side effects. Treatment-resistant depression opens up additional options including TMS, ECT, and ketamine therapy.

Can I switch directly from an SSRI to an alternative?

This depends on the specific alternative and your situation. Some switches allow cross-tapering; others require careful washout periods. MAOIs, for example, require 2-5 weeks between stopping certain medications to prevent dangerous interactions. Never stop antidepressants abruptly. Work with your provider to create a safe switching plan.

How long should I try an alternative before considering it ineffective?

Most antidepressants require 6-8 weeks at therapeutic doses to demonstrate full effectiveness, though some like mirtazapine may show faster onset. Rapid-acting treatments like ketamine can show effects much sooner. Consider switching earlier if you experience intolerable side effects or have severe symptoms.

Generic versions of SNRIs, bupropion, and mirtazapine typically cost similar to generic SSRIs with standard insurance coverage. Specialized treatments vary more: TMS and ECT often have insurance coverage for treatment-resistant depression; esketamine coverage depends on your plan; IV ketamine is typically $400-800 per session without insurance. Innerwell's at-home ketamine therapy costs $54-125 per treatment depending on insurance and plan selection.

Some combinations are evidence-based and commonly used, like adding bupropion to an SNRI, or combining any antidepressant with therapy. Combined strategies often work better than medication alone, particularly for treatment-resistant depression.

SSRIs not working? Explore proven alternatives including SNRIs, bupropion, TMS, and rapid-acting ketamine therapy that can provide relief within hours.

12 SSRI Alternatives for Depression Relief

Introduction

What Are SSRIs?

Why SSRIs Don't Work for Everyone

Medication Alternatives

Non-Medication Alternatives

Rapid-Acting Alternatives: Ketamine Therapy

Comparison at a Glance

Which Alternative Is Right for You?

12 Evidence-Based SSRI Alternatives for Depression Relief

If you've been researching ketamine therapy, you've probably encountered terms like "S-ketamine," "R-ketamine," "esketamine," and "arketamine." It's confusing, and the terminology matters more than it might seem at first.

These aren't interchangeable names for the same thing. S-ketamine and R-ketamine are chemically distinct mirror-image molecules with different uses, side effect profiles, and availability. Understanding the difference helps you make sense of your treatment options.

This guide breaks down what you actually need to know: what each form is, what's available to you, and how they compare for people exploring ketamine for depression and other mental health conditions.

Ketamine exists as two mirror-image molecules called enantiomers. Think of your left and right hands: both have the same components but are oriented differently in space. This seemingly small distinction creates meaningful differences in how each form works.

S-Ketamine (Esketamine) is the FDA-approved form, sold as a nasal spray called Spravato. It received approval in 2019 for treatment-resistant depression and must be administered at certified clinics with two-hour monitoring after each dose.

R-Ketamine (Arketamine) remains experimental. Early research suggested it might offer longer-lasting effects with fewer side effects, but a controlled clinical trial found it wasn't more effective than placebo for depression. It's not available outside clinical trials.

Racemic ketamine contains both forms in equal 50/50 proportions. This is what most IV clinics and at-home programs use. Originally FDA-approved as an anesthetic in the 1960s, it's now commonly prescribed off-label for depression via IV infusion or sublingual tablets.

Both S-ketamine and R-ketamine block NMDA receptors in your brain's glutamate system, a fundamentally different mechanism from traditional antidepressants that work through serotonin. This is why ketamine can produce effects within hours rather than the weeks required by SSRIs.

S-ketamine binds about four times tighter to these receptors. You might assume stronger binding means better results, but research suggests the opposite may be true: racemic ketamine (with both forms) often shows higher response rates than S-ketamine alone in comparative studies. Researchers call this the "potency paradox."

The stronger binding may also explain why S-ketamine causes more pronounced dissociative effects, and why Spravato requires mandatory clinic monitoring.

When ketamine blocks NMDA receptors, it triggers a cascade that can rapidly improve mood: increased glutamate release, activation of pathways that promote new neural connections, and stimulation of brain-derived neurotrophic factor (BDNF). Mental health conditions appear to physically affect brain structures, weakening connections in areas that regulate mood and stress. Ketamine helps rebuild these pathways by promoting synapse formation and enhancing neuroplasticity, your brain's ability to form new neural connections.

This is why many clinicians emphasize pairing ketamine with therapy. The medication opens a window of neuroplasticity; therapeutic support helps you make the most of it. Without that integration, the benefits may fade faster.

Both S-ketamine and R-ketamine activate these processes, but racemic ketamine engages them through both enantiomers working together. For a deeper dive into the mechanics of ketamine, explore our comprehensive guide on ketamine science.

Response rates of 27.7–31.6% for treatment-resistant depression

Long-term retention of 76% at 2 years for stable responders

These results come from large-scale studies involving thousands of people.

Despite promising laboratory research, R-ketamine has not produced comparable results in human clinical trials. The controlled study found that it wasn't superior to placebo, though it was extremely well-tolerated. This disconnect between lab findings and real-world outcomes has limited further development.

Comparative analyses suggest racemic ketamine may show higher response rates than esketamine in some meta-analyses. However, different delivery methods (IV vs. nasal spray) make direct comparisons complicated.

Common side effects include sedation (48–61% of people), dissociation, and blood pressure elevation. These safety concerns are why mandatory two-hour monitoring at certified facilities is required after each dose.

Early research suggests fewer dissociative effects, but since it wasn't more effective than placebo, this tolerability advantage may be moot.

Side effects involve both enantiomers' effects combined. Safety depends heavily on provider protocols. The American Society of Anesthesiologists issued guidance emphasizing that ketamine for mental health should meet the same safety standards as anesthetics, including trained healthcare professionals.

For all forms, long-term monitoring should include screening for bladder symptoms and cardiovascular effects.

Treatment follows a structured protocol: twice-weekly clinic visits for the first month (eight sessions minimum), then tapering to weekly or biweekly based on your response. Each visit requires treatment at a REMS-certified facility with mandatory two-hour monitoring, blood pressure checks, and stability assessment before you can leave.

Medication costs $761–$1,131 per session, with first-month totals reaching $6,088–$9,048 for medication alone; facility and monitoring fees are billed separately. Insurance coverage typically requires documented failure of at least two antidepressants at adequate doses.

Not available outside clinical trials. Given its failure to beat placebo in controlled studies, broader availability may not come.

More accessible and affordable. Compounded racemic ketamine costs approximately $100–150 per month through various providers. At-home ketamine therapy programs offer sublingual tablets without repeated clinic visits or IV infusions.

Insurance coverage varies significantly. Many plans don't cover off-label use, though some at-home providers have secured insurance partnerships.

Innerwell uses racemic ketamine with comprehensive clinical oversight. Unlike medication-delivery services with minimal support or clinic programs requiring repeated visits, Innerwell combines at-home convenience with the therapeutic integration that maximizes ketamine's benefits.

Ketamine opens a window of neuroplasticity, but what you do during that window matters. That's why every Innerwell plan includes licensed psychotherapist guidance, not unlicensed guides or minimal check-ins.

Evaluation: A comprehensive virtual psychiatric assessment by licensed providers (Master's or Doctoral level) determines whether ketamine is appropriate, reviews your medical history and current medications, and creates a personalized protocol.

Delivery: Once approved, sublingual tablets ship securely to your door with dosing instructions and direct clinician access. No clinic visits, no needle sticks, no IV infusions, just the convenience of treatment in your own space.

Preparation and integration: Before your first session, you'll work with a licensed psychotherapist who helps you prepare, set intentions, and understand what to expect. After each session, integration exercises help you process insights and apply them to lasting change.

Ongoing monitoring: Your care team tracks progress continuously, adjusting protocols based on your response. Regular check-ins and secure messaging keep you connected to clinical support.

Pricing: Innerwell's insurance partnerships make treatment accessible at a fraction of competitor costs:

Foundation Plan: $599 with insurance ($998 self-pay) for 8 treatments

Extended Plan: $1,299 with insurance ($1,999 self-pay) for 24 treatments

Per-session: As low as $54 with insurance

Available with insurance coverage in California and New York.

Ready to explore ketamine therapy with comprehensive clinical oversight? Take the free assessment to see if Innerwell's approach might work for you.

The short answer: R-ketamine isn't available outside trials. Your real choice is between S-ketamine (Spravato) and racemic ketamine.

You can commit to twice-weekly clinic visits with two-hour monitoring

At-home racemic ketamine may be better if:

You want therapeutic support built into your treatment

You find the emerging research on racemic formulations compelling

What to watch for: Skip providers that lack comprehensive screening, use unlicensed guides, or offer ketamine without mental health follow-up. The medication alone isn't enough; preparation and integration make the difference.

Find out if ketamine therapy is right for you and evaluate your options.

Which is more effective: S-ketamine or R-ketamine?

S-ketamine has demonstrated effectiveness in large-scale trials with response rates of 27.7–31.6%. R-ketamine failed to beat placebo in controlled trials despite promising preclinical research. Racemic ketamine (containing both) may show superior results in some comparative analyses, though different delivery methods make direct comparisons complicated.

No. R-ketamine is only available in registered clinical trials and has no legal prescribing pathway otherwise. Your practical options are FDA-approved S-ketamine (Spravato) or off-label racemic ketamine through IV clinics or at-home sublingual programs.

Safety depends on the provider and protocol. Spravato is legally prohibited from home use due to its REMS requirements. Racemic ketamine can be prescribed for at-home sublingual use when combined with proper clinical oversight: comprehensive screening, licensed clinicians, preparation and integration support, and ongoing monitoring.

Spravato costs $761–$1,131 per session for medication alone, with first-month totals reaching $6,088–$9,048 plus separate facility fees. At-home racemic ketamine through Innerwell costs as low as $54 per treatment with insurance, or $83–125 per treatment self-pay, including clinical oversight and therapeutic support.

You may experience dissociation (a floating sensation) along with perception changes during treatment. Effects typically peak around 40 minutes and resolve within two hours. Many people find the experience meaningful with proper preparation and intention setting. For details, read about what ketamine therapy feels like.

R-ketamine isn't available outside trials. Compare S-ketamine (Spravato) vs racemic ketamine: efficacy, cost, access, and why at-home may be better.

S-Ketamine vs R-Ketamine: Comparing Effects & Uses | Innerwell

What Are S-Ketamine and R-Ketamine?

How Do They Work Differently?

What Does the Research Show?

Side Effects and Safety

Access and Cost

How Does Innerwell's Approach Work?

Which Option Is Right for You?

S-Ketamine vs R-Ketamine: Comparing Effects & Uses

You're supposed to be glowing. Instead, you're crying in the bathroom while your baby screams, wondering why you can't feel the joy everyone told you would come. Postpartum depression affects approximately 1 in 6 new mothers globally, and finding treatment while caring for a newborn can feel impossible.

Traditional antidepressants take eight to twelve weeks to work. But the reality is you don't have eight to twelve weeks. Your baby needs you now. Therapy requires regular appointments, but arranging childcare when you can barely get dressed feels like a nightmare. And underneath every treatment decision lurks the question: is this safe for my baby if I'm breastfeeding?

Ketamine therapy brings rapid relief, often within days, through Innerwell's at-home program designed for the realities of new motherhood.

Postpartum depression (PPD) is a major depressive disorder that emerges during pregnancy or in the months after childbirth. It's not the "baby blues," those mild mood swings that 80% of mothers experience which resolve within two weeks. PPD is persistent, heavy, and doesn't lift on its own.

PPD affects about 17% of mothers, and roughly half go undiagnosed. Many women suffer in silence because the symptoms feel shameful: you're supposed to be happy, but instead you feel disconnected from your baby, irritable with everyone, unable to sleep even when the baby sleeps, and haunted by thoughts that you're failing at the one thing you're supposed to know how to do.

Here's what makes PPD uniquely cruel: it strikes during the exact window when bonding matters most. The fog of depression creates distance between you and your baby during a developmental period you can't get back. PPD affects not just your mental health but your physical recovery, your relationships, your milk supply, and your child's emotional development.

Traditional Treatments for Postpartum Depression & Their Limitations

Standard treatment starts with SSRIs like Zoloft or Prozac, or therapy approaches like IPT (interpersonal therapy). But the numbers are discouraging: only 37% of women achieve remission with SSRIs within eight weeks. Most mothers don't get full relief from first-line treatments.

The postpartum period makes treatment especially difficult. SSRIs take months to work—months you spend white-knuckling through feeds and diaper changes while waiting to feel better. Many mothers won't take antidepressants at all because of breastfeeding fears, even when the evidence supports safety. And weekly therapy appointments? That requires childcare, transportation, pumping if you're nursing, and energy you simply don't have.

 Ketamine therapy for postpartum depression offers rapid relief when traditional treatments fall short. Learn about the research, safety, and Innerwell's approach.

Therapy

12 Evidence-Based SSRI Alternatives for Depression Relief

S-Ketamine vs R-Ketamine: Comparing Effects & Uses

Ketamine Therapy for Postpartum Depression: Complete Guide

Ketamine Therapy for Panic Disorder: What You Need to Know

Ketamine Therapy Effects: Benefits, Risks & What to Expect

Ketamine Therapy for Psychosis: What You Need to Know

Ketamine vs Esketamine: Key Differences Explained